Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

RESTORE trial results presented at AHA meeting

Nov. 22, 1996

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Nov. 22, 1996

Calcium channel blocker update

Nov. 22, 1996

Pfizer's antiasthma drug R&D

Nov. 20, 1996

Latest findings on the diagnosis and treatment of erectile dysfunction

Nov. 15, 1996

Salagen Tablets more effective given during radiation therapy

Nov. 15, 1996

Rabeprazole + amoxicillin for eradication of H. pylori

Nov. 8, 1996

CV Therapeutics reports novel adenosine antagonist

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...